Cancer risks for MLH1 and MSH2 mutation carriers.
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S, Marchand LL, Newcomb PA, Haile RW, Young GP, James PA, Giles GG, Gunawardena SR, Leggett BA, Gattas M, Boussioutas A, Ahnen DJ, Baron JA, Parry S, Goldblatt J, Young JP, Hopper JL, Jenkins MA.
Dowty JG, et al. Among authors: boussioutas a.
Hum Mutat. 2013 Mar;34(3):490-7. doi: 10.1002/humu.22262.
Hum Mutat. 2013.
PMID: 23255516
Free PMC article.